It has been described how agonists of TNF receptor (TNFR)-2 ameliorate cognitive functions and AD neuropathology [73,74] while TNFR-1 mediates more deleterious effects on cognition and is up-regulated in AD patients [75]. Here, TNFRSF1A is linked to Alzheimer disease.